AIDS vaccine study begins in England.
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D004739:England; D015488:HIV Antigens / Q000009:adverse effects*; D006801:Humans; D010455:Peptides / Q000009:adverse effects*; D014611:Vaccination; D054301:gag Gene Products, Human Immunodeficiency Virus
C052407:HGP-30 peptide, Human immunodeficiency virus-1; D015488:HIV Antigens; D010455:Peptides; D054301:gag Gene Products, Human Immunodeficiency Virus